fbpx

David Sharek

David Sharek is stock portfolio manager at Shareks Stock Portfolios and the founder of The School of Hard Stocks. Sharek's Growth Stock Portfolio has delivered its investors an average return of 18% per year since inception vs. the S&P 500's 10% during that time (2003-2020). David's delivered five years of +40% returns in his 18 year career, including 106% during 2020. David Sharek's book The School of Hard Stocks can be found on Amazon.com.

A Great Summer to Travel

With low gas prices this Summer will be great to travel, leading to more parts sales for O’Reilly Automotive (ORLY).

Momentum Stalled

Last qtr Alexion Pharmaceuticals (ALXN) broke out, but now that momentum has stalled.

Gilead’s A Good Value

Gilead Sciences (GILD) is such a good value, but does it have the growth to go higher?

Chipotle Could Drop $150

This is a good time to short Chipotle (CMG) as the stock is worth $150 less than CMG is selling for.

$12.50 by 2020

Celgene’s (CELG) management has a target of $12.50 in EPS by 2020. Here’s what that means for CELG.

Apple is Back in a Big Way

Apple (AAPL) is back with 20% profit growth — and a 14 P/E — so I will add it to the Growth Portfolio & Aggressive Growth Portfolio.

Sitting on Dead Money

For the 2nd year in a row it looks like MasterCard (MA) is dead money, thus I will sell it from the Growth Portfolio.

Google Disappoints. Again.

Google (GOOGL)missed estimates again, and I will sell the stock from the Growth Portfolio as I see growth slowing.

Expenses Hampering Profits

Alibaba (BABA) has lowered estimates the past two qtrs as higher expenses are hampering profits.

Stable Growth With a Catalyst

Biogen (BIIB) provides stable earnings growth and BIIB may have another blockbuster coming soon.

Not a member? Sign up here for $25 a month.